PARK CITY, UT

3 days / 6 sessions
180 attendees / 80 surgeons
Engaging and Thoughtful Discussion

February 2-4, 2017
Join the

Discussions

Our discussion topics are carefully selected by our expert Directors in an effort to promote real discussions that affect best practices and inform the surgeons of new technologies to treat complex problems.


Future of

Health Care

We will provide an update on legislative changes, data being used to analyze surgeons’ performance, the recent changes at NASS and the reality of insurance status changing from private insurance to Obamacare.

Read more



Cervical

Spinal Surgery

Focused area of discussions are radiologic assessment of spine fusion, zero profile cages replacing ACDF, cervical plating remains the standard of care, prosthetic discs, cervical balance and includes two engaging debates.

Read more


Emerging

Technologies

We dive into new technologies such as: Techniques of dural repair, hemostatic technologies, surfacing on interbody implants, porous PEEK technologies and discuss whether there is value in surgery for Adult Spinal Deformity.

Read more


Spinal

Deformity

In this session we debate whether grade II/III spondylolisthesis is a deformity case and how it should (or shouldn’t) be treated, sagittal balance, and whether MIS will replace most open surgery or if it is a passing fad.

Read more


Best

Paper Review

In this session we will dive into the five best paper reviews as well as share stories of our attendees worst complications. We will open the eyes of the group to new ideas and potentially help to avoid further complications.

Read more


Previous

Programs

The course Directors work hard to provide an experience unlike any other conference. This meeting provides an intimate setting to learn from some of the best and is a platform for sharing ideas to improve our patient outcomes.

Explore

Interested?

The Selby Spine Conference is designed for surgeons with a special interest in the treatment of spinal disorders. The latest advances and controversies in the field will be presented through didactic lectures, open discussions, debates and case presentations. Selby Spine grew out of the Keystone Meeting that Dr. David Selby began in Keystone, Colorado in 1986.

Meet the

Directors

Completely pursue scalable customer service through sustainable potentialities. Holistically pontificate installed base portals. Dynamically innovate resource-leveling customer service.
http://www.selbyspine.org/wp-content/uploads/2016/08/JJ-Abitbol.jpg

Jean Jacques “JJ“

Abitbol

MD, FRCSC

http://www.selbyspine.org/wp-content/uploads/2015/12/fessler_richard_rmc.jpg

Richard

Fessler

MD, PhD


http://www.selbyspine.org/wp-content/uploads/2015/12/Pierce_Nunley-bw.jpeg

Pierce

Nunley

MD

http://www.selbyspine.org/wp-content/uploads/2015/12/Small2-1.jpg

John

Small

MD

http://www.selbyspine.org/wp-content/uploads/2015/12/Employees_DrueDeAngelis_WEB.jpg

Drue

De Angelis

Industry Liaison

http://www.selbyspine.org/wp-content/uploads/2015/12/Josh.jpg

Josh

Sandberg

Industry Liaison


Latest news

From our Partners at OrthoSpineNews.com

http://www.selbyspine.org/wp-content/uploads/2018/12/Johnson-and-Johnson-9-750x500-1.jpg
December 17, 2018

NEW BRUNSWICK, N.J., Dec. 17, 2018 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the company’s common stock. “Based on our continued strong performance and, more importantly, the confidence we have in our business going forward, the Board of Directors and management team believe that […]

http://www.selbyspine.org/wp-content/uploads/2018/12/zurich_biotech_kuros_sealants_orthobiologics-1-12bto-1.jpg
December 17, 2018

SCHLIEREN (ZURICH), Switzerland, Dec. 17, 2018 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) has completed a transformational year, having realized first sales of its MagnetOs bone graft substitute in the U.S. and Europe and raised capital to support the roll-out of MagnetOs, and fund the Phase II clinical trial of fibrin-PTH (KUR-113) in spinal fusion. […]

http://www.selbyspine.org/wp-content/uploads/2018/12/ConforMIS-Logo3-12bto2-1.jpg
December 14, 2018

BILLERICA, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique anatomy, today announced it is implementing steps to improve its overall business model, including the prioritization of certain […]

Partners

We couldn’t do it without our partner companies. Thank you all very much!

Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image
Aspect image